Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Spingotec Therapeutics divulges DPP3 inhibitors

Nov. 22, 2017

First-in-human results provided for TR-Pharm's anti-interleukin-1 biologic RPH-104

Nov. 15, 2017

New yohimbine analogues synthesized at the University of Florida

Nov. 15, 2017

Novel NLRP3 inflammasome inhibitors presented by IFM Therapeutics

Nov. 3, 2017

Novel leukotriene A-4 hydrolase inhibitors identified at Novartis

Oct. 31, 2017

Allergan presents new fMet-Leu-Phe receptor modulators

Oct. 30, 2017

University of Texas, Immune Sensor divulge new cyclic GMP-AMP synthase inhibitors

Oct. 19, 2017

Blade Therapeutics patents novel calpain inhibitors

Oct. 4, 2017

Galapagos presents new sphingosine 1-phosphate receptor antagonists

Sep. 19, 2017

Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation

Sep. 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.